Skip to main content
SpringerLink
Log in

PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Ovarian cancer is the most common cause of gynecologic cancer death. Both morphologically and immunohistochemically, metastatic mucinous tumors are the best mimickers of mucinous ovarian tumors; its pathogenesis still remains a mystery. PAX2 and PAX8 immunohisyochemistries are useful for differentiating numerous primary tumour types from metastatic ones. There are few studies in literature about PAX expressions in mucinous and seromucinous tumors. None of these are takes into account the histologic type (whether it is seromucinous or mucinous) or the metastatic origin. With this purpose hematoxylin and eosine slides of ovarian mucinous and seromucinous tumors were re-evaluated and one block was chosen for each case. The study included 76 ovarian mucinous and seromucinous tumors of the ovary reported in Hacettepe University department of pathology between 2000 and 2013. Tissue microarray (TMA) was designed from the chosen blocks, PAX2, PAX8, CDX2 immunostains was preformed to the TMA slides. As a result, most of the metastatic cases were negative for PAX2 (91.2 %) and PAX8 (86.3 %), many were diffusely and strongly positive for CDX2 (68.2 %). Seromucinous tumors were devoid of CDX2 expression; but all cases (except one) displayed strong and diffuse positivity with PAX8. In other words differing from mucinous tumors, seromucinous tumors show strong PAX8 positivity–similar to serous tumors. This study shows that PAX8 and CDX2 could be useful in differentiating primary mucinous from metastatic tumor. Furthermore unlike the homogeneity in seromucinous tumors for PAX8 and CDX2 mucinous tumors shows heterogeneity with different expression patterns.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Seidman JD, Kurman RJ, Ronnett BM (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 27(7):985–993

    Article  PubMed  Google Scholar 

  2. Ulbright TM, Roth LM, Stehman FB (1984) Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer 53(5):1164–1174

    Article  CAS  PubMed  Google Scholar 

  3. Lagendijk JH, Mullink H, Van Diest PJ, Meijer GA, Meijer CJ (1998) Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites. Hum Pathol 29(5):491–497

    Article  CAS  PubMed  Google Scholar 

  4. Chu PG, Chung L, Weiss LM, Lau SK (2011) Determining the site of origin of mucinous adenocarcinoma: an immunohistochemical study of 175 cases. Am J Surg Pathol 35(12):1830–1836

    Article  PubMed  Google Scholar 

  5. Zhai QJ, Ozcan A, Hamilton C, Shen SS, Coffey D, Krishnan B, Truong LD (2010) PAX-2 expression in non-neoplastic, primary neoplastic, and metastatic neoplastic tissue: a comprehensive immunohistochemical study. Appl Immunohistochem Mol Morphol 18(4):323–332

    Article  CAS  PubMed  Google Scholar 

  6. Ozcan A, Liles N, Coffey D, Shen SS, Truong LD (2011) PAX2 and PAX8 expression in primary and metastatic mullerian epithelial tumors: a comprehensive comparison. Am J Surg Pathol 35(12):1837–1847

    Article  PubMed  Google Scholar 

  7. Ozcan A, Shen SS, Hamilton C, Anjana K, Coffey D, Krishnan B, Truong LD (2011) PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study. Mod Pathol 24(6):751–764

    Article  CAS  PubMed  Google Scholar 

  8. Jones JM, Cui XS, Medina D, Donehower LA (1999) Heterozygosity of p21WAF1/CIP1 enhances tumor cell proliferation and cyclin D1-associated kinase activity in a murine mammary cancer model. Cell Growth Differ 10(4):213–222

    CAS  PubMed  Google Scholar 

  9. Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih Ie M, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. New Engl J Med 363(16):1532–1543

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu CH, Mao TL, Vang R, Ayhan A, Wang TL, Kurman RJ, Shih Ie M (2012) Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 31(4):297–303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Okada S, Ohaki Y, Ogura J, Ishihara M, Kawamura T, Kumazaki T (2004) Computed tomography and magnetic resonance imaging findings in cases of dermoid cyst coexisting with surface epithelial tumors in the same ovary. J Comput Assist Tomogr 28(2):169–173

    Article  PubMed  Google Scholar 

  12. Ueda G, Sawada M, Ogawa H, Tanizawa O, Tsujimoto M (1993) Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. Gynecol Oncol 51(2):219–223. doi:10.1006/gyno.1993.1276

    Article  CAS  PubMed  Google Scholar 

  13. Kerr SE, Flotte AB, McFalls MJ, Vrana JA, Halling KC, Bell DA (2013) Matching maternal isodisomy in mucinous carcinomas and associated ovarian teratomas provides evidence of germ cell derivation for some mucinous ovarian tumors. Am J Surg Pathol 37(8):1229–1235

    Article  PubMed  Google Scholar 

  14. Seidman JD, Khedmati F (2008) Exploring the histogenesis of ovarian mucinous and transitional cell (brenner) neoplasms and their relationship with walthard cell nests: a study of 120 tumors. Arch Pathol Lab Med 132(11):1753–1760

    PubMed  Google Scholar 

  15. Cuatrecasas M, Villanueva A, Matias-Guiu X, Prat J (1997) K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 79(8):1581–1586

    Article  CAS  PubMed  Google Scholar 

  16. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry JP, Scolyer RA, Smith AN, Bali A, Vanden Bergh P, Baron-Hay S, Scott C, Fink D, Hacker NF, Sutherland RL, O'Brien PM (2006) A distinct molecular profile associated with mucinous epithelial ovarian cancer. Brit J Cancer 94(6):904–913

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ronnett BM, Kajdacsy-Balla A, Gilks CB, Merino MJ, Silva E, Werness BA, Young RH (2004) Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 35(8):949–960

    Article  PubMed  Google Scholar 

  18. Kurman RJ, Shih Ie M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433–443. doi:10.1097/PAS.0b013e3181cf3d79

    Article  PubMed  PubMed Central  Google Scholar 

  19. McMahon CP (2000) Ephraim McDowell, jane todd crawford, and the origins of oophorectomy. N C Med J 61(1):401–402

    CAS  PubMed  Google Scholar 

  20. Pinto PB, Derchain SF, Andrade LA (2012) Metastatic mucinous carcinomas in the ovary: a practical approach to diagnosis related to gross aspects and to immunohistochemical evaluation. Int J Gynecol Pathol 31(4):313–318. doi:10.1097/PGP.0b013e31823f844d

    Article  PubMed  Google Scholar 

  21. Laury AR, Perets R, Piao H, Krane JF, Barletta JA, French C, Chirieac LR, Lis R, Loda M, Hornick JL, Drapkin R, Hirsch MS (2011) A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol 35(6):816–826. doi:10.1097/PAS.0b013e318216c112

    Article  PubMed  Google Scholar 

  22. Pickel H, Tamussino K (2003) History of gynecological pathology: XIV. Hermann johannes pfannenstiel. Int J Gynecol Pathol 22(3):310–314. doi:10.1097/01.PGP.0000070844.85581.A1

    Article  PubMed  Google Scholar 

  23. Kobel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5(12):e232. doi:10.1371/journal.pmed.0050232

    Article  PubMed  PubMed Central  Google Scholar 

  24. Nonaka D, Chiriboga L, Soslow RA (2008) Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32(10):1566–1571

    Article  PubMed  Google Scholar 

  25. Tabrizi AD, Kalloger SE, Kobel M, Cipollone J, Roskelley CD, Mehl E, Gilks CB (2010) Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol 29(2):99–107

    Article  PubMed  Google Scholar 

  26. Maeda D, Shih Ie M (2013) Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol 20(1):45–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Blaustein A, Kurman RJ (2011) Blaustein's pathology of the female genital tract, 6th edn. Springer, New York, NY p 736–739

Download references

Acknowledgments

The project is sponsored by Hacettepe University Scientific Research Projects Coordination Unit Project number is: 013 D05101 007 - 310.

Author information

Authors and Affiliations

  1. Department of Pathology, Hacettepe University, Faculty of Medicine, Ankara, Turkey

    D. Ates Ozdemir & A. Usubutun

Authors
  1. D. Ates Ozdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Usubutun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Ates Ozdemir.

Ethics declarations

Conflict of Interest

We declare that we have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ates Ozdemir, D., Usubutun, A. PAX2, PAX8 and CDX2 Expression in Metastatic Mucinous, Primary Ovarian Mucinous and Seromucinous Tumors and Review of the Literature. Pathol. Oncol. Res. 22, 593–599 (2016). https://doi.org/10.1007/s12253-016-0040-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-016-0040-2

Keywords

Search

Navigation